New Faculty Friday: Yasmmyn Salinas, genetic epidemiologist, obesity specialist, social entrepreneur
Today we spotlight, Yasmmyn Salinas, assistant professor in the Department of Chronic Disease Epidemiology. Salinas has a Ph.D. (2019) and an M.P.H. (2014) in public health chronic disease epidemiology from YSPH. She has a B.S. in molecular cellular and developmental biology from Yale University (2010). Salinas did her postdoctoral training in Associate Professor Andrew DeWan’s lab at YSPH and she is a former McDougal Graduate Teaching Fellow.
Sentinel Lymph Node Biopsy Provides no Benefit for Stage Zero Breast Cancer, Yale School of Public Health Study Finds
Older women with a very early, non-invasive breast cancer known as ductal carcinoma in situ (DCIS), gain no long-term benefit from undergoing a sentinel lymph node biopsy to see if the cancer has spread, new research by the Yale School of Public Health has found.
Regulatory Approvals and the Future of Cancer Care With Vincent DeVita
Vincent DeVita, MD, professor of medicine at Yale Cancer Center and former president of ACS, debates with Chadi some of the ideas laid out in his book, "The Death of Cancer," most notably the utility of randomized controlled trials in regulatory approvals.
More women in U.S. receive 3-D mammography but disparities remain
Use of 3-D mammography, an advanced form of breast cancer screening, has risen rapidly in recent years, according to Yale Cancer Center researchers in a new study. But adoption of the technology varies widely, reflecting emerging disparities in care, they said.
Study: Accuracy of Five Self‐Report Screening Instruments for Substance Use in Pregnancy
Nearly one-fourth of pregnant women report having used alcohol, tobacco, or other substances in the past month, yet current screening questionnaires used by physicians may not accurately identify many of them. Kimberly A. Yonkers, MD, Professor of Psychiatry, of Epidemiology (Chronic Diseases) and of Obstetrics, Gynecology, and Reproductive Services at Yale School of Medicine, was the senior researcher among investigators across three universities who compared results of five commonly used questionnaires against laboratory testing.
Dense Breast Reporting Regulations Increasing
For the past several years, states have slowly been enacting laws that require radiologists to alert women, as part of their mammography results, if they have dense breast tissue. Legislation adoption has been slow, but steady, even though there’s been little definitive clarity about the impact of providing this information.
Yale Study Finds Link Between Medicaid Expansion and Equity in Cancer Care
Racial disparities in timely cancer treatment disappeared in states that expanded Medicaid under the Affordable Care Act (ACA), according to an analysis of over 30,000 health records led by researchers at Yale Cancer Center. The findings were presented at the American Society of Clinical Oncology (ASCO) 2019 annual meeting.
Questions raised over cancer drugs in FDA's accelerated approval program
Many cancer patients and oncologists may turn to the US Food and Drug Administration's accelerated approval program, which provides access to new cancer drugs faster -- especially when a life-threatening cancer needs swift treatment or relief.
Yonkers, Forray Co-PIs on New Grant to Study Medication Delivery for Pregnant Women with Opioid Use Disorders
Kimberly Yonkers, MD, Professor of Psychiatry, of Epidemiology (Chronic Diseases) and of Obstetrics, Gynecology, and Reproductive Services, and Ariadna Forray, MD, Associate Professor of Psychiatry, are co-principal investigators on a new $5.5 million grant to study models to improve delivery of office-based medication treatment for pregnant women with opioid use disorder in prenatal clinics.